Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide by Powles, John et al.
 Global, regional and national sodium intakes in 1990 and 2010: a
systematic analysis of 24 h urinary sodium excretion and dietary
surveys worldwide
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Powles, John, Saman Fahimi, Renata Micha, Shahab
Khatibzadeh, Peilin Shi, Majid Ezzati, Rebecca E Engell,
Stephen S Lim, Goodarz Danaei, and Dariush Mozaffarian.
2013. “Global, regional and national sodium intakes in 1990 and
2010: a systematic analysis of 24 h urinary sodium excretion and
dietary surveys worldwide.” BMJ Open 3 (12): e003733.
doi:10.1136/bmjopen-2013-003733.
http://dx.doi.org/10.1136/bmjopen-2013-003733.
Published Version doi:10.1136/bmjopen-2013-003733
Accessed February 19, 2015 3:07:43 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879481
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA
Global, regional and national sodium
intakes in 1990 and 2010: a systematic
analysis of 24 h urinary sodium
excretion and dietary surveys worldwide
John Powles,1 Saman Fahimi,1 Renata Micha,2,3 Shahab Khatibzadeh,2 Peilin Shi,2
Majid Ezzati,4 Rebecca E Engell,5 Stephen S Lim,5 Goodarz Danaei,2,6
Dariush Mozaffarian,2,7 on behalf of the Global Burden of Diseases Nutrition
and Chronic Diseases Expert Group (NutriCoDE)
To cite: Powles J, Fahimi S,
Micha R, et al. Global,
regional and national sodium
intakes in 1990 and 2010: a
systematic analysis of 24 h
urinary sodium excretion and
dietary surveys worldwide.
BMJ Open 2013;3:e003733.
doi:10.1136/bmjopen-2013-
003733
▸ Prepublication history and
additional material for this
paper is available online. To
view these files please visit
the journal online
(http://dx.doi.org/10.1136/
bmjopen-2013-003733).
JP and SF contributed
equally.
Received 5 August 2013
Revised 9 October 2013
Accepted 5 November 2013
For numbered affiliations see
end of article.
Correspondence to
Dr John Powles;
jwp11@cam.ac.uk
ABSTRACT
Objectives: To estimate global, regional (21 regions)
and national (187 countries) sodium intakes in adults
in 1990 and 2010.
Design: Bayesian hierarchical modelling using all
identifiable primary sources.
Data sources and eligibility: We searched and
obtained published and unpublished data from 142
surveys of 24 h urinary sodium and 103 of dietary
sodium conducted between 1980 and 2010 across 66
countries. Dietary estimates were converted to urine
equivalents based on 79 pairs of dual measurements.
Modelling methods: Bayesian hierarchical modelling
used survey data and their characteristics to estimate
mean sodium intake, by sex, 5 years age group and
associated uncertainty for persons aged 20+ in 187
countries in 1990 and 2010. Country-level covariates
were national income/person and composition of food
supplies.
Main outcome measures: Mean sodium intake
(g/day) as estimable by 24 h urine collections, without
adjustment for non-urinary losses.
Results: In 2010, global mean sodium intake was
3.95 g/day (95% uncertainty interval: 3.89 to 4.01).
This was nearly twice the WHO recommended limit of
2 g/day and equivalent to 10.06 (9.88–10.21) g/day of
salt. Intake in men was ∼10% higher than in women;
differences by age were small. Intakes were highest in
East Asia, Central Asia and Eastern Europe (mean
>4.2 g/day) and in Central Europe and Middle East/
North Africa (3.9–4.2 g/day). Regional mean intakes in
North America, Western Europe and Australia/New
Zealand ranged from 3.4 to 3.8 g/day. Intakes were
lower (<3.3 g/day), but more uncertain, in sub-Saharan
Africa and Latin America. Between 1990 and 2010,
modest, but uncertain, increases in sodium intakes
were identified.
Conclusions: Sodium intakes exceed the
recommended levels in almost all countries with small
differences by age and sex. Virtually all populations
would benefit from sodium reduction, supported by
enhanced surveillance.
INTRODUCTION
Excess sodium intake raises blood pressure
(BP),1 2 a major risk factor for cardiovascular
disease3 4 and increases risk of stomach
cancer,5 6 a leading fatal cancer globally.7 On
the basis of established risks across the
current range of population intake levels, the
major international and national agencies
have prioritised sodium reduction to
decrease the burdens of non-communicable
disease.8–11 Such efforts have been limited, at
least in part, by the absence of reliable and
comparable data on sodium intake for most
Strengths and limitations of this study
▪ This is the first study to produce comprehensive
and comparable estimates of sodium intake and
their uncertainties, globally.
▪ We identified and made use of a much larger set
of primary data sources than previous collations.
▪ Our Bayesian estimation model used all available
data by converting self-reported dietary values to
comparable 24 h urine values and was informed by
regional hierarchies and country-level covariates.
▪ In the absence of established conventions for
measuring and reporting sodium intakes we have
used 24 h urinary excretion, uncorrected for non-
renal losses, as a proxy measure. Variation in non-
renal (sweat) losses associated with climate or
activity levels could introduce additional biases.
▪ Use of biochemical markers to assess and control
the completeness of urine collections was uncom-
mon, impeding adjustment for likely downward
biases from incomplete collections.
▪ Twenty-four hours urine collections mostly came
from small surveys that were not based on
national probability sampling with consequent
sampling bias.
▪ Primary data were deficient for much of the
global population.
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of the countries.12 This has made it difﬁcult to quantify
global, regional or national levels of dietary sodium and
the corresponding preventable disease burdens.
Changes in national, regional and global sodium intakes
over time are also not well established.
We therefore systematically reviewed and accessed the
published and unpublished country-speciﬁc surveys of
sodium intakes from around the world as part of the
2010 Global Burden of Diseases (GBD), Injuries and
Risk Factors Study. We developed quantitative methods
to produce comparable global, regional and country-
speciﬁc estimates of sodium intake, by age and sex sub-
groups, in 1990 and 2010.
METHODS
Study design
We estimated mean sodium intake and its uncertainty by
age and sex for 187 countries in 1990 and 2010. Our
strategy included three steps: (1) systematic searches for
data sources from around the world on individual-level
sodium intake, including by age and sex subgroups; (2)
retrieval of data, including assessment of data quality,
representativeness, missingness and uncertainty, and
quantiﬁcation of measurement comparability across dif-
ferent survey methods and (3) application of an hier-
archical Bayesian estimation model to incorporate
missingness, comparability and sampling and modelling
uncertainty to estimate sodium intake by age, sex,
country and time worldwide.
Identification of surveys, access and extraction
Between October 2008 and November 2011, we per-
formed systematic searches to identify urine-based and
diet-based surveys (ﬁgure 1). The overall search strategy
and results have been described.13 14 Sources for diet-
based measurements were primarily national surveys that
had incorporated sampling weights, as appropriate. For
countries with no national dietary surveys identiﬁed,
other potential sources were considered, including sub-
national surveys, household budget survey data, baseline
measurements in large cohort studies, the WHO
InfoBase and the STEPS database, published government
reports, published sources not previously identiﬁed and
unpublished data. These searches were complemented
by extensive direct contacts with local experts and
requests for detailed data.
For urine-based assessments, we searched MEDLINE
using the following terms: ((World regions (Mesh)) OR
(Name of countries)) AND (salt OR sodium OR Na)
AND (intake OR ingest* OR eat* OR consum* OR diet*
OR urin* OR excret*) Limits:Humans, All Adult: 19+
years, publication date from 1 January 1980.
We also searched for national dietary survey reports
and manually searched the reference lists of retrieved
articles. We searched publications and web pages of
organisations engaged in sodium reduction at national
(eg, UK Food Standards Agency), regional (eg,
European salt reduction programme) and international
levels (eg, World Action on Salt and Health) and con-
tacted the nutritional departments of WHO regional
ofﬁces. Where duplicate sources were identiﬁed we
retained the report with most detail and with most infor-
mation on the primary metric.
Surveys could be included if they were performed
after 1980 and were from a sample that was representa-
tive of a national (or if no national survey, a subna-
tional) population; if the assessment methods included
24 h urinary excretion measurements, a diet assessment
tool (eg, diet record, diet recall, food frequency ques-
tionnaire or both and if there was no evidence suggest-
ive of major selection bias. For example, we excluded
studies based exclusively on individuals with hyperten-
sion or on pregnant women. Surveys conducted at differ-
ent locations within a country were counted as different
surveys unless they were part of a formal multistage sam-
pling design intended to characterise a larger (regional
or national) population.
In sum, we identiﬁed 142 urine-based surveys and 103
diet-based surveys—with 26 of each forming paired
surveys of the same population (ﬁgure 1 and table 1).
Data retrieval and standardisation
As the published exposure data were often limited or not
in the required format, we obtained data by direct con-
tacts with government ofﬁcials, scientists and survey
report authors from across the world, who joined our
group as corresponding members (see list of contributors
and see online supplementary table). These individuals
provided us with either raw data or standardised analyses
using an electronic form.13 Survey characteristics were
extracted including date of ﬁeldwork, sampling methods,
proportion participating, representativeness, population
characteristics, the number of participants by age and sex
strata, types and the number of measurements (urine,
diet including type of dietary tool), validation methods,
energy adjustment (for diet-based data) and mean and
SD of sodium intake by age and sex groups. To reduce
the measurement errors in dietary estimates by account-
ing for tendencies to under-report or over-report the
intakes of all foods,15 dietary data were energy-
standardised to 2000 kcal/day (8.37 MJ/day). Urinary
data were not standardised to energy.
Owing to known larger measurement errors in diet-
based methods,16–18 we chose 24 h urinary excretion as
our primary metric, and dietary estimates as our second-
ary metric. We estimated the quantitative relationship
between urine and dietary measurements using 79 data-
points from 26 surveys having data on the same indivi-
duals in both metrics, and used these results to estimate
urinary excretions corresponding to the dietary values in
the remaining dietary surveys (ﬁgure 2). Consequently,
our ﬁnal estimates represent sodium ‘intake’ using 24 h
urine collections as the reference. We elected not to
adjust these ﬁnal estimates for non-urinary losses (eg,
sweat) because urinary excretion accounts, on an
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average, for ∼90% of dietary intake19–21 and also to
enhance the comparability with prior estimates of
sodium intake (mostly reported as unadjusted 24 h
urinary sodium excretion). The possibility that sweat
losses vary systematically with climate needs to be clari-
ﬁed by further research. We also did not attempt to
adjust these estimates for potential incomplete collec-
tions, which are common even in research settings.22
Thus, our ﬁnal estimates of dietary intake can be consid-
ered conservative estimates of true sodium consumption.
Bayesian hierarchical model
To account for differences in missingness, representative-
ness and measurement methods and to incorporate and
quantify uncertainty, we speciﬁed a Bayesian hierarchical
model (using the DisMod-MR model developed as part
the Global Burden of Disease Project) to estimate the
mean sodium intake across the world by sex, age and
country for two calendar years—1990 and 2010. The data
from country-speciﬁc age and sex subgroups were used
simultaneously as inputs, with country, regional and
Figure 1 Search strategies for global sodium exposure data: urine-based (left) and diet-based (right). Note: The black dashed
lines show dietary Na assessment studies that were identified through the search for 24 h urinary sodium excretion studies.
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global random effects. This structure allowed the model
to borrow information across countries and regions
as necessary, using spatial-temporal regression and
Gaussian process regression, while accounting for and
quantifying the resulting statistical uncertainties.
Representativeness (national with or without probability
sampling, subnational) were included as a survey-level
covariate. Time-varying country-level covariates further
informed the estimates, including lag-distributed national
per capita income (inﬂation and purchasing power parity
adjusted23) and national dietary patterns characterised by
scores on four components from a dimension reduction
through principal components analysis of 15 diet com-
position variables from the Food and Agriculture
Organisation (FAO) food balance sheets. As sodium
intakes may be non-linearly associated with age, relation-
ships with age were modelled using a cubic spline.
We ﬁtted the Bayesian model with the Markov chain
Monte Carlo algorithm and ran 1000 iterations.
Posterior distributions of mean sodium intake for each
country by age and sex subgroups were obtained, incorp-
orating and reﬂecting the above sources of uncertainty.
Ninety-ﬁve per cent uncertainty intervals were obtained
from the 2.5th and 97.5th centiles of the posterior
distributions.
Intakes were estimated from the model for 5-year age
intervals and by sex of the adults aged 20 years or more
for each country for 1990 and 2010. Regional estimates
were calculated as population-weighted averages of the
constituent country estimates. Intakes for each country,
region and time period are reported, both actual intakes
(potentially of greater relevance to assessing contribu-
tions to local disease burdens) and age-standardised
intakes24 (for comparing the levels across populations
and over time).
Further details on the modelling process and its
outputs are provided in the online methodology
supplement.
Table 1 Classification of 245 surveys of sodium intake by exposure metric reported, period of survey and national
representativeness, with pairs of surveys reporting in both metrics identified
GBD region
Surveys
(n=245) Survey characteristics (n=219 counting survey pairs as 1)
Urine
based
Diet
based
Contributing surveys and survey
pairs by metric Period
Nationally
representative
Urine
based
only
Diet
based
only
Both
(survey
pairs)* Total
1980–
1998
1999–
2010
Asia, Central 1 0 1 0 0 1 1 0 1 (100%)
Asia, East 11 15 8 12 3 23 21 2 3 (13%)
Asia Pacific high income† 12 11 7 5 6 18 14 4 4 (22%)
Asia, South 2 4 2 4 0 6 3 3 0 (0%)
Asia, Southeast 2 3 2 3 0 5 2 3 2 (40%)
Australasia† 8 1 8 1 0 9 6 3 1 (11%)
Caribbean 5 2 5 2 0 7 6 1 2 (29%)
Europe, Central 4 2 4 2 0 6 2 4 3 (50%)
Europe, Eastern 1 1 1 1 0 2 2 0 1 (50%)
Europe, Western† 51 31 46 27 4 77 45 32 27 (35%)
Latin America, Andean 0 0 0 0 0 0 0 0 NA
Latin America, Central 3 1 3 1 0 4 3 1 1 (25%)
Latin America, Southern 1 1 1 1 0 2 1 1 1 (50%)
Latin America, Tropical 0 2 0 2 0 2 0 2 1 (50%)
North America, High Income† 21 14 11 4 10 25 20 5 4 (16%)
North Africa Middle East 2 7 2 7 0 9 2 7 4 (44%)
Oceania 1 2 1 2 0 3 3 0 3 (100%)
Sub-Saharan Africa, East 3 2 3 2 0 5 5 0 0 (0%)
Sub-Saharan Africa, Central 0 0 0 0 0 0 0 0 NA
Sub-Saharan Africa, Southern 7 4 4 1 3 8 4 4 1 (13%)
Sub-Saharan Africa, West 7 0 7 0 0 7 5 2 0 (0%)
Total 142 103 116 77 26* 219 145 74 55 (35%‡)
*These 26 surveys with measurements in both metrics reported on all participants provided the 79 paired urine-diet datapoints that were used
to estimate the relationship between the two metrics (figure 2); the diet-based datapoints from these 26 surveys were not subsequently used
in the final estimation model.
†High income.
‡Unweighted mean for 19 regions with at least 1 survey.
GBD, Global Burden of Diseases; NA, not applicable.
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RESULTS
Data sources
We identiﬁed and obtained data from 245 surveys,
including 142 reporting 24 h urinary sodium data and
103 reporting dietary sodium data, with 26 of each
forming urine/diet survey pairs. These surveys were con-
ducted in 66 countries comprising 74% of the global
adult population. Sixty-one per cent (149) of the surveys
were conducted in high-income regions and 40% (96)
in low-income and mid-income regions (table 1; details
for each contributing survey are provided in the online
supplementary table). East Asia (23 surveys) was the only
low-income or mid-income region with more than 10
surveys. Counting as a datapoint each estimate for an
age–sex stratum, the identiﬁed surveys provided 1346
datapoints (mean: 5.5/survey), of which 651 were urine
based and 695 were diet based. More than half (376/
651) of the urine-based datapoints came from the
Intersalt study, a major international study with standar-
dised protocols conducted between 1985 and 1987.25
Fifty datapoints, all in European regions, were from col-
lections biochemically validated for completeness using
para-amino benzoic acid.26 Ten countries had at least 20
urine-based datapoints, including the USA (86), the UK
(86), Japan (48), China (41), Italy (33), Belgium (24),
Finland (24), Germany (24), New Zealand (22) and the
Netherlands (20). Urine-based data were relatively
scarce in the highest age groups, with only two urine-
based datapoints for age groups 70+ years; in contrast,
97 diet-based datapoints were available for these older
age groups.
Global and regional sodium intakes
In 2010 global, mean (95% uncertainty interval) sodium
intake in adults was 3.95 (3.89–4.01) g/day, equivalent
to salt intakes of 10.06 (9.88–10.21) g/day (based on the
assumption, conventional in this context, that all the
sodium comes from salt). Globally, mean intake in men
was, as expected, higher than that in women: 4.14
(4.04–4.23) vs 3.77 (3.69–3.85) g/day, respectively. In
every region, sodium intake was lower in women,
ranging from 8.9% lower in South Asia to 10.7% lower
in Western Europe. Given these consistent, modest dif-
ferences, additional ﬁndings are presented for both
sexes combined.
Interestingly, we also identiﬁed a relatively little vari-
ation in sodium intakes by age. Globally, mean intakes
rose by ∼6% from age 25–29 (3.78 g/day) to 40–44
(4.04 g/day), and then remained relatively constant
thereafter. This pattern was broadly consistent across
each of the 21 GBD Study regions (ﬁgure 3).
In contrast to small within-region differences by age or
sex, marked differences in intake were identiﬁed across
regions (ﬁgures 4 and 5). Asian regions had highest
intakes—East Asia (mean, 95% uncertainty interval)
4.80 (4.59–5.02) g/day, Asia Paciﬁc High Income
(mainly Japan and South Korea) 5.00 (4.85–5.16) g/day,
and Central Asia 5.51 (5.11–5.95) g/day—corresponding
to daily salt intakes of 12.21, 12.71 and 14.01 g, respect-
ively. Very high intakes were also seen in Eastern Europe
(4.18 (3.95–4.41) g/day, Central Europe (3.92 (3.73–
4.12) g/day and the Middle East and North Africa (3.92
(3.74–4.12) g/day. Among high-income Western regions,
sodium consumption was 3.44 (3.32–3.55) g/day in
Australia/New Zealand, 3.62 (3.52–3.72) g/day in the
USA/Canada and 3.81 (3.72–3.91) g/day in Western
Europe—equivalent to salt intakes of 8.75, 9.21 and
9.69 g/day, respectively.
Sub-Saharan Africa, Latin America and the Caribbean
and Oceania tended to have lower estimated intakes, but
also were based on fewest data sources among all the
regions, with resulting larger uncertainties. For example,
estimated intakes in sub-Saharan Africa ranged from
2.18 (2.05–2.32) g/day in Eastern sub-Saharan Africa to
2.76 (2.58–2.95) g/day in Western sub-Saharan Africa
and estimated intake in Oceania was 2.48 (2.18–2.80)
g/day. Mean intakes were similar or higher in Latin
America and the Caribbean, including 2.61 (2.40–2.83)
Figure 2 Relationship between measured urinary sodium
and measured dietary sodium in 79 age/sex strata from 26
survey pairs. Note: The solid line represents the cross-walk
regression line (linear regression of log-transformed urinary
sodium on log-transformed dietary sodium); and the dotted
lines, the 95% uncertainty intervals. With the partial exception
of 8 age and sex strata (all from 2 of the 3 InterMap study
sites in China) in which urinary sodium levels were
systematically higher relative to their dietary levels, good
agreement was seen between the two metrics. The regression
coefficients obtained from this analysis informed the Bayesian
hierarchical model of the relationship between the two
metrics. Adding a term to identify the survey sites generating
the outlying points increased the R2 to 0.79 but it was not
retained because this term did not correspond to a generic
survey characteristic that could be used in predictions outside
the cross-walk dataset. The wider uncertainty bounds for the
modelled relationship in the upper part of its range reflect the
influence of the outliers.
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g/day in the Caribbean, and 3.19 (3.03–3.34) g/day in
Central Latin America. Intake in Tropical Latin America
(mainly Brazil) was higher than in other Latin American
regions and, at 4.11 (4.01–4.22) g/day, exceeded that
for the USA/Canada.
National sodium intakes
We identiﬁed substantial variation in estimated sodium
intakes across nations (ﬁgure 6A and table 2). The statis-
tical uncertainty around the estimated intakes for indi-
vidual countries (ﬁgure 6B) was larger than that for
world regions, especially for countries with no primary
data. Thus, relative rankings across different nations
should be interpreted in the light of their relative uncer-
tainty levels.
In Western Europe, a region with relatively low uncer-
tainty, estimated mean intakes ranged from 3.28 (2.99–
3.59) g/day (Denmark) to 4.43 (4.23–4.62) g/day (Italy).
Estimated intakes in the Netherlands, Belgium, Germany
and Iceland ranged from 3.33 to 3.59 g/day; in another
12 Western European countries, from 3.62 (3.41–3.86)
g/day (Switzerland) to 4.03 (3.78–4.27) g/day (Spain);
and in Cyprus, Luxemburg, Malta, Portugal and Italy,
from 4.06 to 4.43 g/day.
Estimated intakes within North Africa/Middle East were
also diverse, ranging from 3.13 (2.77–5.54) g/day in
Lebanon to 5.37 (4.85–5.92) g/day in Bahrain. In Eastern
sub-Saharan Africa, estimated consumption was higher in
Mauritius (5.45 (4.57–6.50) g/day) than in other
neighbouring countries (mean intakes ranging from 1.47 to
4.32 g/day).
In other regions, less variation in sodium intake was
identiﬁed. For example, sodium consumption was very
similar in the USA (3.61 (3.51–3.71) g/day) versus
Canada (3.72 (3.59–3.84) g/day). In addition, relatively
small within-region differences were observed in
Australia/New Zealand, Eastern Europe, South Asia and
each of the regions of Latin America.
Overall in 2010, estimated mean intakes in 181 of 187
countries, whose total adult population accounted for
99.2% of the world adult population, exceeded the WHO
recommendation of 2.00 g/day sodium (∼5 g/day salt).27
In 119 countries (with 88.3% of the world’s adult popula-
tion), estimated mean intakes exceeded this recommended
amount by at least 1 g/day; and in 51 countries (44.8% of
the world’s adult population), estimated mean intakes were
more than double this recommended amount.
Changes over time
Globally, between 1990 and 2010, modest, statistically non-
signiﬁcant global increases were seen, from 4.02 (3.93–
4.11) to 4.14 (4.04–4.23) g/day in men and from 3.63
(3.55–3.71) to 3.77 (3.69–3.85) g/day in women. By
region, estimated increases were larger for East Asia, from
4.37 (4.18–4.58) to 4.80 (4.59–5.02) g/day, and Eastern
Europe, from 3.76 (3.55–3.97) to 4.18 (3.95–4.41) g/day
(for both sexes combined). These estimated increases
appeared sensitive to the large proportion of urine-based
Figure 3 Sodium intakes in g/day by age, for regions and globally, both sexes combined, 2010.
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data in earlier years that were collected in Intersalt (1985–
1987). When only diet-based data were evaluated, the dir-
ection of secular change tended to reverse (data not
shown). Thus, estimates of trends over time should be
interpreted cautiously. Figure 5 and table 2 show changes
in age-standardised estimates for regions and countries,
respectively.
DISCUSSION
Our ﬁndings provide systematically assessed and compre-
hensive evidence on global, regional and national intake
levels and patterns of sodium consumption, including by
age and sex. Several ﬁndings are notable. Within regions
and countries, only small differences were evident com-
paring younger with older adults or men with women.
This suggests relatively constant and common exposures
to sodium within populations. On the other hand,
marked differences were evident between regions and
between countries. Interestingly, these differences were
not strongly related to national income, suggesting that
in contrast to many other dietary components that are
linked to national wealth or afﬂuence, sodium intake is
more strongly inﬂuenced by other factors. For example,
the geographic distribution of highest intakes from East
Asia to Eastern and Central Europe suggests a ‘Silk
Road’ pattern, implying shared retentions from past
transportation and food cultures such as use of salt for
food preservation.28
A recent Institute of Medicine committee concluded
that, based only on studies of the association between
sodium intake and incidence of clinical events (ie, ignoring
effects on BP), evidence was insufﬁcient to conclusively
choose between modest (eg, 2.3 g/day) and low (eg,
1.5 g/day) sodium intakes as long-term targets for popula-
tions.29 The resulting controversy over this somewhat
Figure 4 Mean (95% uncertainty interval) sodium intakes (g/day) in 2010 in 21 Global Burden of Diseases regions. Note:
Regions are ranked by levels in both sexes combined, ages 20+. Intakes are not age-standardised.
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narrowly based judgement overshadowed their other main
conclusion that, considered collectively, the evidence indi-
cated a positive relationship between high sodium intakes
and cardiovascular events and was consistent with
BP-raising effects of dietary sodium. Numerous other orga-
nisations have systematically reviewed the evidence and
concluded that intakes of sodium above the levels variously
speciﬁed in the range 1.2–2.4 g/day increase cardiovascu-
lar risk.11 27 30 Thus, while identiﬁed optimal target intakes
have varied from 1.20 to 2.4 g/day,27 30 31 all have consist-
ently concluded that sodium intakes above these levels are
adverse for health. Our ﬁndings demonstrate that, whether
modest (2–2.4 g/day) or low (1.20–1.5 g/day) target
intakes are designated as optimal, virtually every nation in
the world, and each age and sex group within these
nations, exceed these optimal intakes.
The Intersalt study provided the ﬁrst extensive body of
comparable urine-based data on sodium consumption
globally, with results from 52 surveys in 30 countries
reported in 1988 and 1989.25 In 2009, Brown et al12 pro-
duced a tabular update of 11 diet-based and 26 urine-
based surveys published after Intersalt. We are not aware
of any other reports that have estimated national sodium
intake levels globally.
Strengths and innovations of our investigation can also
be highlighted. We systematically identiﬁed and
extracted data from around the world on both urinary
and dietary sodium, including many sources of previ-
ously unavailable data. We evaluated and incorporated
the evidence for systematic differences between urinary
and dietary estimates, increasing the comparability and
allowing us to draw on the different strengths of each. In
contrast with diet-based surveys many of which were
based on national probability samples, urine-based
surveys were often of smaller size and representative
only of local populations. Our model takes advantage of
all available raw data in the world; a cross-walk to render
self-reported dietary values more comparable to 24 h
Figure 5 Mean (95% uncertainty interval) age-standardised sodium intakes (g/day) in 1990 and 2010 in 21 Global Burden of
Diseases regions. Note: The upper symbol for each pair is for 2010. Regions are ranked by levels in both sexes combined, ages 20+.
8 Powles J, Fahimi S, Micha R, et al. BMJ Open 2013;3:e003733. doi:10.1136/bmjopen-2013-003733
Open Access
urine values, based on empirical relations between these
measures; and then the relation between these data and
global country-level covariates (national income per
person, age, sex, FAO factor analysis) in a Bayesian hier-
archical fashion.
Potential limitations should be considered. Primary
data sources were limited or missing in many countries.
Our model dealt with this by ‘borrowing’ information
within and across countries, regions and time, based on
both country-level and survey-level covariates; it also
incorporated missingness and types of available data to
quantify the ﬁnal uncertainty. For regions and their
constituent countries where primary exposure data are
limited or absent (eg, sub-Saharan Africa, central and
Latin America, Andean), relative uncertainty is corres-
pondingly greater: their Monte Carlo SEs exceed 9% of
their means, compared with 2.5% for the relatively
data-rich region of Western Europe. For data-deﬁcient
regions ﬁnal estimates correspond to their priors, which
depend in turn on spatio-temporal ‘borrowing’ and on
the use of covariates. Model outputs for such regions
(see ﬁgures S1, S3 and S4 in the online methodology
supplement) show that the coefﬁcients for the ﬁxed
effects of the FAO diet composition components
Figure 6 Sodium intakes by country, for ages 20+, average of both sexes, in 2010. (A) Mean intakes in g/day and (B) relative
uncertainty*. Note: *Monte Carlo SEs divided by the mean of these intake estimates.
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Table 2 Age-standardised estimated sodium intakes (g/day) in 1990 and 2010, persons aged 20 and over, by country (95% uncertainty intervals)
Total Males Females
1990 2010 1990 2010 1990 2010
Afghanistan 3.29 (2.71–3.95) 3.39 (2.79–4.06) 3.44 (2.61–4.46) 3.55 (2.63–4.69) 3.12 (2.36–4.06) 3.22 (2.42–4.17)
Albania 3.47 (2.89–4.16) 3.67 (3.05–4.34) 3.64 (2.83–4.62) 3.86 (2.98–5.00) 3.31 (2.56–4.29) 3.48 (2.67–4.37)
Algeria 3.91 (3.32–4.59) 4.28 (3.59–5.00) 4.09 (3.19–5.17) 4.51 (3.50–5.72) 3.73 (2.97–4.74) 4.07 (3.20–5.08)
Andorra 3.56 (3.04–4.16) 3.81 (3.21–4.44) 3.85 (3.05–4.83) 4.01 (3.19–5.07) 3.29 (2.59–4.05) 3.61 (2.84–4.53)
Angola 2.46 (2.07–2.90) 2.49 (2.06–2.97) 2.58 (2.03–3.28) 2.61 (2.02–3.35) 2.35 (1.82–2.94) 2.38 (1.86–3.07)
Antigua and Barbuda 2.71 (2.28–3.23) 2.67 (2.23–3.18) 2.85 (2.19–3.64) 2.81 (2.18–3.55) 2.58 (2.01–3.26) 2.54 (1.98–3.24)
Argentina 3.01 (2.93–3.10) 3.00 (2.92–3.08) 3.16 (3.03–3.29) 3.15 (3.03–3.26) 2.87 (2.76–2.99) 2.87 (2.76–2.98)
Armenia 4.84 (4.04–5.67) 4.92 (4.13–5.77) 5.07 (4.03–6.31) 5.19 (4.06–6.57) 4.65 (3.64–5.86) 4.71 (3.69–5.89)
Australia 3.38 (3.26–3.50) 3.42 (3.29–3.55) 3.55 (3.37–3.75) 3.59 (3.39–3.77) 3.22 (3.05–3.40) 3.26 (3.09–3.42)
Austria 3.89 (3.57–4.22) 3.95 (3.63–4.31) 4.20 (3.73–4.73) 4.16 (3.70–4.64) 3.60 (3.22–4.06) 3.76 (3.29–4.28)
Azerbaijan 4.55 (3.83–5.34) 5.06 (4.31–5.98) 4.79 (3.74–6.08) 5.31 (4.18–6.71) 4.35 (3.44–5.56) 4.85 (3.83–6.13)
Bahamas 3.03 (2.53–3.60) 2.99 (2.48–3.54) 3.18 (2.41–4.10) 3.13 (2.41–3.97) 2.89 (2.24–3.65) 2.86 (2.22–3.67)
Bahrain 4.40 (4.03–4.82) 5.38 (4.85–5.91) 4.56 (4.05–5.11) 5.57 (4.88–6.31) 4.15 (3.68–4.69) 5.05 (4.42–5.72)
Bangladesh 3.68 (3.09–4.41) 3.54 (2.98–4.21) 3.84 (3.02–4.93) 3.71 (2.89–4.67) 3.51 (2.76–4.41) 3.38 (2.63–4.32)
Barbados 3.40 (3.12–3.69) 3.42 (3.11–3.76) 3.56 (3.17–3.99) 3.59 (3.12–4.09) 3.25 (2.87–3.65) 3.25 (2.85–3.69)
Belarus 4.00 (3.39–4.72) 4.35 (3.69–5.16) 4.19 (3.28–5.22) 4.55 (3.55–5.69) 3.83 (2.98–4.72) 4.17 (3.27–5.24)
Belgium 3.48 (3.30–3.67) 3.45 (3.23–3.68) 3.76 (3.48–4.05) 3.64 (3.32–3.96) 3.21 (2.98–3.46) 3.27 (2.98–3.60)
Belize 2.67 (2.38–3.02) 2.62 (2.34–2.93) 2.80 (2.38–3.29) 2.75 (2.31–3.21) 2.55 (2.17–3.01) 2.50 (2.10–2.93)
Benin 2.86 (2.53–3.28) 2.85 (2.49–3.22) 3.01 (2.50–3.57) 2.97 (2.47–3.52) 2.73 (2.27–3.26) 2.73 (2.28–3.25)
Bhutan 3.72 (3.13–4.33) 3.64 (3.07–4.24) 3.88 (3.05–4.86) 3.80 (2.97–4.78) 3.55 (2.82–4.46) 3.45 (2.74–4.26)
Bolivia, Plurinational State of 3.51 (2.97–4.11) 3.59 (3.02–4.20) 3.67 (2.90–4.54) 3.77 (3.01–4.69) 3.35 (2.63–4.16) 3.41 (2.71–4.30)
Bosnia and Herzegovina 3.26 (2.71–3.93) 3.46 (2.88–4.15) 3.43 (2.62–4.41) 3.62 (2.78–4.59) 3.10 (2.38–4.07) 3.32 (2.58–4.25)
Botswana 2.49 (2.07–2.95) 2.53 (2.15–2.97) 2.63 (2.05–3.33) 2.66 (2.06–3.30) 2.37 (1.85–2.97) 2.40 (1.90–3.00)
Brazil 3.89 (3.78–3.99) 4.11 (4.01–4.22) 4.08 (3.93–4.23) 4.31 (4.17–4.46) 3.70 (3.57–3.83) 3.92 (3.79–4.07)
Brunei Darussalam 4.40 (3.70–5.13) 4.42 (3.71–5.16) 4.59 (3.62–5.73) 4.62 (3.59–5.83) 4.18 (3.27–5.24) 4.21 (3.27–5.30)
Bulgaria 3.63 (3.40–3.85) 3.62 (3.39–3.87) 3.82 (3.48–4.17) 3.80 (3.45–4.18) 3.45 (3.14–3.78) 3.45 (3.13–3.79)
Burkina Faso 2.91 (2.46–3.46) 2.88 (2.40–3.41) 3.07 (2.41–3.91) 3.04 (2.38–3.80) 2.77 (2.15–3.53) 2.74 (2.11–3.47)
Burundi 1.62 (1.31–1.99) 1.73 (1.42–2.09) 1.70 (1.25–2.26) 1.82 (1.38–2.36) 1.56 (1.14–2.07) 1.65 (1.23–2.15)
Cambodia 4.54 (3.81–5.38) 4.41 (3.73–5.18) 4.76 (3.69–6.07) 4.65 (3.68–5.87) 4.37 (3.41–5.52) 4.20 (3.26–5.24)
Cameroon 2.07 (1.82–2.35) 2.09 (1.84–2.36) 2.18 (1.81–2.59) 2.19 (1.81–2.58) 1.97 (1.64–2.32) 1.99 (1.68–2.38)
Canada 3.55 (3.45–3.66) 3.71 (3.58–3.83) 3.74 (3.58–3.90) 3.88 (3.69–4.08) 3.37 (3.22–3.52) 3.53 (3.36–3.70)
Cape Verde 2.99 (2.55–3.51) 3.25 (2.74–3.89) 3.16 (2.47–3.92) 3.42 (2.63–4.33) 2.87 (2.21–3.63) 3.10 (2.39–3.86)
Central African Republic 2.75 (2.32–3.25) 2.80 (2.33–3.29) 2.89 (2.24–3.62) 2.94 (2.30–3.71) 2.62 (2.06–3.27) 2.66 (2.05–3.37)
Chad 2.87 (2.42–3.38) 2.87 (2.43–3.37) 3.00 (2.33–3.78) 3.02 (2.37–3.76) 2.74 (2.12–3.38) 2.72 (2.15–3.39)
Chile 2.79 (2.38–3.29) 2.80 (2.35–3.31) 2.92 (2.30–3.74) 2.92 (2.29–3.70) 2.67 (2.11–3.37) 2.69 (2.13–3.36)
China 4.42 (4.24–4.63) 4.83 (4.62–5.05) 4.63 (4.35–4.93) 5.05 (4.71–5.39) 4.20 (3.94–4.49) 4.60 (4.31–4.88)
Colombia 4.12 (3.77–4.45) 4.09 (3.77–4.43) 4.31 (3.82–4.83) 4.29 (3.83–4.81) 3.93 (3.50–4.43) 3.91 (3.48–4.36)
Comoros 1.69 (1.42–2.02) 1.67 (1.41–1.98) 1.78 (1.39–2.26) 1.74 (1.35–2.22) 1.61 (1.22–2.04) 1.59 (1.24–2.03)
Congo 2.30 (1.95–2.70) 2.25 (1.88–2.67) 2.42 (1.89–3.05) 2.35 (1.83–2.97) 2.18 (1.69–2.73) 2.15 (1.63–2.78)
Congo, the Democratic Republic of the 2.27 (1.90–2.66) 2.42 (2.05–2.84) 2.39 (1.84–2.95) 2.54 (1.97–3.24) 2.16 (1.68–2.74) 2.31 (1.82–2.90)
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Table 2 Continued
Total Males Females
1990 2010 1990 2010 1990 2010
Costa Rica 2.98 (2.51–3.50) 3.18 (2.71–3.73) 3.13 (2.49–3.91) 3.32 (2.56–4.18) 2.83 (2.20–3.56) 3.03 (2.40–3.76)
Côte dIvoire 2.78 (2.48–3.13) 2.80 (2.50–3.13) 2.90 (2.45–3.42) 2.94 (2.48–3.45) 2.64 (2.22–3.11) 2.65 (2.25–3.11)
Croatia 3.25 (2.73–3.81) 3.71 (3.15–4.34) 3.42 (2.70–4.28) 3.88 (3.04–4.80) 3.10 (2.44–3.92) 3.54 (2.80–4.45)
Cuba 2.80 (2.36–3.29) 2.64 (2.23–3.12) 2.94 (2.32–3.67) 2.75 (2.16–3.46) 2.66 (2.07–3.27) 2.52 (1.99–3.21)
Cyprus 3.76 (3.17–4.45) 4.06 (3.41–4.76) 4.05 (3.18–5.12) 4.29 (3.26–5.36) 3.49 (2.71–4.39) 3.83 (3.03–4.81)
Czech Republic 3.74 (3.16–4.44) 3.98 (3.37–4.74) 3.97 (3.14–5.02) 4.17 (3.31–5.31) 3.53 (2.75–4.36) 3.80 (3.00–4.75)
Denmark 3.53 (3.23–3.82) 3.27 (2.98–3.58) 3.80 (3.36–4.29) 3.43 (3.00–3.88) 3.26 (2.87–3.67) 3.11 (2.72–3.55)
Djibouti 2.29 (1.90–2.72) 2.36 (1.94–2.81) 2.39 (1.85–3.07) 2.48 (1.91–3.14) 2.19 (1.67–2.81) 2.24 (1.74–2.84)
Dominica 2.62 (2.21–3.10) 2.69 (2.30–3.20) 2.74 (2.14–3.44) 2.82 (2.13–3.60) 2.51 (1.96–3.22) 2.57 (1.96–3.29)
Dominican Republic 2.45 (2.08–2.85) 2.60 (2.21–3.03) 2.57 (2.01–3.26) 2.70 (2.14–3.38) 2.32 (1.83–2.86) 2.50 (1.99–3.12)
Ecuador 2.88 (2.41–3.38) 3.03 (2.55–3.57) 3.00 (2.37–3.76) 3.17 (2.47–4.01) 2.76 (2.16–3.45) 2.88 (2.29–3.66)
Egypt 3.63 (3.10–4.22) 3.68 (3.13–4.32) 3.81 (3.01–4.75) 3.85 (3.00–4.82) 3.45 (2.75–4.33) 3.52 (2.77–4.36)
El Salvador 3.19 (2.64–3.79) 3.19 (2.71–3.71) 3.35 (2.60–4.28) 3.36 (2.63–4.22) 3.04 (2.37–3.85) 3.05 (2.39–3.81)
Equatorial Guinea 2.50 (2.12–3.00) 2.30 (1.90–2.78) 2.61 (2.07–3.24) 2.40 (1.80–3.08) 2.37 (1.89–3.04) 2.20 (1.67–2.90)
Eritrea 2.32 (1.93–2.73) 2.37 (2.00–2.82) 2.43 (1.88–3.11) 2.50 (1.96–3.18) 2.22 (1.71–2.78) 2.25 (1.76–2.83)
Estonia 3.49 (3.30–3.69) 3.95 (3.69–4.23) 3.67 (3.40–3.96) 4.15 (3.76–4.56) 3.33 (3.07–3.60) 3.77 (3.43–4.16)
Ethiopia 2.30 (1.92–2.70) 2.27 (1.95–2.67) 2.42 (1.87–3.07) 2.38 (1.87–2.97) 2.19 (1.72–2.74) 2.17 (1.72–2.71)
Fiji 2.86 (2.41–3.35) 2.87 (2.41–3.41) 2.99 (2.34–3.76) 3.01 (2.36–3.84) 2.73 (2.16–3.42) 2.74 (2.13–3.43)
Finland 3.73 (3.52–3.95) 3.85 (3.63–4.07) 4.02 (3.70–4.39) 4.05 (3.72–4.40) 3.44 (3.16–3.74) 3.65 (3.35–3.94)
France 3.70 (3.52–3.91) 3.77 (3.58–3.97) 4.00 (3.72–4.30) 3.96 (3.66–4.28) 3.41 (3.17–3.65) 3.58 (3.31–3.86)
Gabon 1.93 (1.58–2.36) 2.01 (1.63–2.45) 2.02 (1.53–2.62) 2.09 (1.55–2.76) 1.83 (1.39–2.35) 1.92 (1.42–2.54)
Gambia 3.04 (2.58–3.61) 3.07 (2.59–3.58) 3.18 (2.51–4.05) 3.22 (2.56–4.06) 2.88 (2.24–3.63) 2.93 (2.27–3.73)
Georgia 4.73 (3.95–5.60) 5.30 (4.49–6.26) 4.95 (3.94–6.29) 5.57 (4.44–7.03) 4.53 (3.55–5.72) 5.07 (3.96–6.29)
Germany 3.45 (3.24–3.68) 3.54 (3.36–3.73) 3.73 (3.42–4.07) 3.72 (3.43–4.02) 3.18 (2.91–3.47) 3.36 (3.13–3.61)
Ghana 2.44 (2.19–2.73) 2.35 (2.09–2.61) 2.56 (2.19–2.98) 2.45 (2.09–2.88) 2.32 (2.02–2.71) 2.24 (1.89–2.62)
Greece 3.55 (2.92–4.25) 3.77 (3.16–4.52) 3.82 (2.92–4.91) 3.97 (3.11–5.03) 3.29 (2.53–4.27) 3.58 (2.76–4.53)
Grenada 2.44 (2.07–2.85) 2.61 (2.20–3.09) 2.55 (2.02–3.21) 2.73 (2.14–3.48) 2.33 (1.83–2.91) 2.48 (1.92–3.18)
Guatemala 2.86 (2.52–3.22) 2.94 (2.60–3.28) 2.99 (2.50–3.53) 3.08 (2.59–3.63) 2.73 (2.31–3.19) 2.81 (2.38–3.29)
Guinea 2.71 (2.29–3.22) 2.77 (2.33–3.26) 2.84 (2.23–3.58) 2.92 (2.30–3.64) 2.59 (2.04–3.27) 2.62 (2.06–3.25)
Guinea-Bissau 2.94 (2.48–3.48) 3.03 (2.55–3.61) 3.09 (2.44–3.87) 3.17 (2.49–4.09) 2.80 (2.23–3.50) 2.90 (2.25–3.66)
Guyana 2.36 (1.98–2.78) 2.45 (2.05–2.93) 2.47 (1.91–3.14) 2.56 (2.02–3.30) 2.26 (1.78–2.88) 2.34 (1.82–2.98)
Haiti 2.43 (2.02–2.86) 2.66 (2.23–3.15) 2.56 (2.00–3.14) 2.78 (2.17–3.50) 2.31 (1.79–2.94) 2.54 (1.98–3.26)
Honduras 2.88 (2.42–3.41) 2.95 (2.49–3.48) 3.02 (2.40–3.75) 3.07 (2.38–3.88) 2.75 (2.11–3.49) 2.84 (2.24–3.55)
Hungary 4.28 (3.90–4.67) 4.23 (3.87–4.57) 4.50 (3.94–5.13) 4.43 (3.91–4.95) 4.07 (3.57–4.62) 4.04 (3.60–4.50)
Iceland 3.53 (3.15–3.90) 3.58 (3.24–3.97) 3.79 (3.23–4.33) 3.77 (3.22–4.34) 3.25 (2.78–3.78) 3.38 (2.92–3.90)
India 3.78 (3.69–3.87) 3.72 (3.63–3.82) 3.95 (3.82–4.07) 3.88 (3.73–4.02) 3.61 (3.49–3.73) 3.56 (3.44–3.68)
Indonesia 3.43 (3.07–3.82) 3.36 (3.02–3.76) 3.59 (3.09–4.18) 3.53 (3.02–4.09) 3.28 (2.82–3.81) 3.21 (2.77–3.75)
Iran, Islamic Republic of 3.85 (3.46–4.27) 4.02 (3.64–4.44) 4.03 (3.46–4.64) 4.21 (3.65–4.85) 3.67 (3.17–4.20) 3.83 (3.33–4.37)
Iraq 3.46 (2.94–4.09) 3.76 (3.19–4.46) 3.64 (2.86–4.61) 3.95 (3.12–5.00) 3.30 (2.63–4.18) 3.59 (2.85–4.51)
Ireland 3.61 (3.24–4.06) 3.74 (3.35–4.18) 3.91 (3.35–4.57) 3.93 (3.38–4.58) 3.32 (2.84–3.85) 3.55 (3.01–4.14)
Israel 3.68 (3.20–4.17) 3.79 (3.27–4.37) 3.97 (3.21–4.81) 4.00 (3.20–4.91) 3.40 (2.79–4.08) 3.59 (2.91–4.32)
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Table 2 Continued
Total Males Females
1990 2010 1990 2010 1990 2010
Italy 4.31 (4.11–4.51) 4.42 (4.22–4.61) 4.65 (4.30–4.98) 4.65 (4.34–4.96) 3.99 (3.72–4.26) 4.19 (3.92–4.45)
Jamaica 1.90 (1.76–2.06) 1.92 (1.77–2.08) 2.00 (1.81–2.22) 2.01 (1.79–2.26) 1.82 (1.63–2.03) 1.84 (1.63–2.06)
Japan 4.71 (4.54–4.89) 4.89 (4.71–5.08) 4.93 (4.67–5.19) 5.12 (4.85–5.41) 4.50 (4.27–4.75) 4.68 (4.43–4.93)
Jordan 3.54 (3.00–4.19) 4.13 (3.47–4.87) 3.69 (2.93–4.62) 4.31 (3.41–5.48) 3.38 (2.67–4.19) 3.95 (3.04–5.00)
Kazakhstan 4.92 (4.17–5.74) 5.98 (5.07–7.14) 5.16 (4.07–6.41) 6.31 (4.95–7.98) 4.72 (3.66–5.84) 5.70 (4.47–7.21)
Kenya 1.43 (1.30–1.58) 1.48 (1.34–1.62) 1.50 (1.29–1.71) 1.55 (1.34–1.77) 1.37 (1.19–1.58) 1.41 (1.22–1.60)
Kiribati 2.18 (1.80–2.65) 2.22 (1.82–2.68) 2.27 (1.72–2.97) 2.31 (1.72–3.05) 2.07 (1.59–2.70) 2.14 (1.60–2.79)
Korea, Democratic People’s Republic of 3.34 (2.75–3.95) 3.79 (3.16–4.46) 3.49 (2.70–4.39) 4.01 (3.07–5.21) 3.20 (2.46–4.03) 3.59 (2.79–4.55)
Korea, Republic of 4.92 (4.68–5.17) 5.21 (4.98–5.48) 5.15 (4.79–5.52) 5.46 (5.12–5.81) 4.70 (4.39–5.04) 4.98 (4.66–5.32)
Kuwait 3.66 (3.31–4.05) 3.88 (3.46–4.31) 3.81 (3.32–4.36) 4.01 (3.45–4.60) 3.46 (3.02–3.95) 3.65 (3.13–4.19)
Kyrgyzstan 5.09 (4.29–5.98) 5.38 (4.55–6.32) 5.34 (4.30–6.64) 5.64 (4.43–7.12) 4.88 (3.79–6.04) 5.14 (4.08–6.41)
Lao People’s Democratic Republic 4.58 (3.80–5.44) 4.45 (3.75–5.27) 4.78 (3.83–6.02) 4.69 (3.63–5.98) 4.39 (3.43–5.53) 4.23 (3.31–5.36)
Latvia 3.58 (3.03–4.24) 4.19 (3.57–5.01) 3.75 (2.97–4.74) 4.37 (3.41–5.45) 3.43 (2.74–4.30) 4.02 (3.20–5.08)
Lebanon 2.60 (2.34–2.88) 3.13 (2.78–3.54) 2.72 (2.32–3.15) 3.30 (2.75–3.89) 2.50 (2.13–2.91) 2.98 (2.49–3.52)
Lesotho 2.66 (2.18–3.14) 2.62 (2.21–3.11) 2.79 (2.13–3.56) 2.76 (2.16–3.49) 2.55 (1.94–3.23) 2.50 (1.92–3.18)
Liberia 2.64 (2.23–3.14) 2.68 (2.23–3.17) 2.76 (2.12–3.49) 2.82 (2.20–3.60) 2.52 (2.01–3.17) 2.55 (1.96–3.26)
Libyan Arab Jamahiriya 3.74 (3.14–4.45) 4.24 (3.55–5.01) 3.90 (3.06–4.97) 4.45 (3.50–5.60) 3.54 (2.76–4.50) 4.03 (3.15–5.08)
Lithuania 3.60 (3.04–4.27) 4.07 (3.47–4.74) 3.77 (3.00–4.64) 4.27 (3.44–5.38) 3.45 (2.73–4.34) 3.90 (3.06–4.79)
Luxembourg 3.87 (3.29–4.56) 4.07 (3.42–4.82) 4.18 (3.27–5.20) 4.28 (3.36–5.37) 3.57 (2.81–4.60) 3.85 (2.99–4.88)
Macedonia, the former Yugoslav Republic of 3.30 (2.77–3.90) 3.91 (3.31–4.55) 3.48 (2.75–4.47) 4.10 (3.21–5.09) 3.13 (2.47–3.98) 3.72 (2.93–4.64)
Madagascar 2.15 (1.83–2.59) 2.20 (1.85–2.58) 2.25 (1.75–2.86) 2.31 (1.81–2.88) 2.05 (1.61–2.61) 2.09 (1.65–2.65)
Malawi 1.63 (1.45–1.83) 1.66 (1.47–1.86) 1.71 (1.45–2.00) 1.73 (1.46–2.03) 1.56 (1.32–1.84) 1.58 (1.33–1.86)
Malaysia 3.42 (3.11–3.76) 3.57 (3.25–3.93) 3.57 (3.12–4.07) 3.74 (3.29–4.29) 3.27 (2.86–3.75) 3.40 (2.95–3.87)
Maldives 3.68 (3.00–4.49) 3.31 (2.58–4.17) 3.84 (2.77–5.05) 3.47 (2.37–4.88) 3.50 (2.56–4.65) 3.14 (2.18–4.26)
Mali 3.21 (2.71–3.74) 3.15 (2.67–3.76) 3.38 (2.69–4.28) 3.31 (2.57–4.20) 3.05 (2.38–3.86) 3.01 (2.35–3.80)
Malta 3.88 (3.53–4.25) 4.10 (3.74–4.50) 4.19 (3.66–4.75) 4.31 (3.78–4.89) 3.58 (3.14–4.03) 3.90 (3.44–4.45)
Marshall Islands 2.49 (2.11–2.94) 2.55 (2.15–3.01) 2.60 (2.05–3.31) 2.68 (2.12–3.40) 2.37 (1.87–3.00) 2.43 (1.88–3.05)
Mauritania 3.10 (2.61–3.69) 2.97 (2.49–3.48) 3.25 (2.53–4.15) 3.12 (2.43–3.99) 2.96 (2.32–3.75) 2.84 (2.21–3.57)
Mauritius 5.05 (4.23–5.93) 5.45 (4.57–6.50) 5.28 (4.10–6.65) 5.71 (4.40–7.28) 4.83 (3.77–6.20) 5.20 (4.06–6.60)
Mexico 2.71 (2.54–2.90) 2.76 (2.57–2.94) 2.85 (2.59–3.14) 2.89 (2.62–3.17) 2.58 (2.35–2.85) 2.63 (2.39–2.89)
Micronesia, Federated States of 2.51 (2.11–2.94) 2.56 (2.17–3.03) 2.62 (2.06–3.29) 2.68 (2.12–3.37) 2.39 (1.84–3.00) 2.44 (1.88–3.04)
Moldova, Republic of 3.59 (3.03–4.31) 3.95 (3.32–4.65) 3.80 (3.00–4.81) 4.13 (3.27–5.28) 3.41 (2.72–4.29) 3.79 (2.93–4.79)
Mongolia 5.18 (4.90–5.46) 5.14 (4.84–5.43) 5.43 (5.02–5.86) 5.38 (4.95–5.84) 4.94 (4.60–5.31) 4.91 (4.54–5.33)
Montenegro 3.15 (2.63–3.72) 3.63 (3.08–4.23) 3.31 (2.59–4.16) 3.81 (3.03–4.79) 2.99 (2.33–3.75) 3.45 (2.76–4.30)
Morocco 3.96 (3.34–4.66) 4.31 (3.67–5.06) 4.17 (3.28–5.21) 4.53 (3.55–5.78) 3.77 (2.97–4.65) 4.11 (3.24–5.12)
Mozambique 2.13 (1.79–2.51) 2.24 (1.86–2.65) 2.24 (1.75–2.84) 2.36 (1.85–2.98) 2.04 (1.60–2.57) 2.13 (1.67–2.75)
Myanmar 4.56 (3.81–5.37) 4.49 (3.75–5.29) 4.77 (3.68–5.99) 4.71 (3.63–5.96) 4.36 (3.43–5.56) 4.27 (3.36–5.36)
Namibia 2.59 (2.20–3.05) 2.64 (2.24–3.09) 2.72 (2.10–3.43) 2.78 (2.17–3.43) 2.47 (1.92–3.12) 2.51 (2.00–3.15)
Nepal 3.87 (3.27–4.57) 3.89 (3.30–4.59) 4.06 (3.22–5.09) 4.07 (3.23–5.20) 3.69 (2.89–4.63) 3.73 (2.89–4.61)
The Netherlands 3.44 (3.25–3.65) 3.32 (3.10–3.56) 3.72 (3.44–4.02) 3.50 (3.17–3.84) 3.17 (2.93–3.46) 3.15 (2.87–3.45)
New Zealand 3.27 (3.15–3.41) 3.47 (3.33–3.63) 3.44 (3.25–3.64) 3.65 (3.43–3.89) 3.12 (2.94–3.30) 3.31 (3.11–3.51)
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Table 2 Continued
Total Males Females
1990 2010 1990 2010 1990 2010
Nicaragua 3.15 (2.65–3.78) 3.22 (2.72–3.83) 3.30 (2.56–4.22) 3.37 (2.57–4.26) 3.00 (2.33–3.83) 3.09 (2.41–3.88)
Niger 3.11 (2.60–3.66) 2.92 (2.48–3.44) 3.24 (2.54–4.04) 3.05 (2.37–3.82) 2.98 (2.32–3.74) 2.79 (2.17–3.47)
Nigeria 2.81 (2.50–3.17) 2.82 (2.51–3.17) 2.94 (2.51–3.45) 2.96 (2.52–3.48) 2.69 (2.29–3.18) 2.69 (2.30–3.17)
Norway 3.67 (3.10–4.36) 3.80 (3.24–4.49) 3.96 (3.10–4.96) 4.01 (3.15–5.06) 3.38 (2.63–4.18) 3.58 (2.77–4.51)
Oman 3.37 (2.81–4.01) 3.78 (3.17–4.46) 3.50 (2.70–4.38) 3.93 (3.08–4.93) 3.18 (2.50–4.00) 3.56 (2.82–4.46)
Pakistan 4.03 (3.42–4.73) 3.91 (3.32–4.66) 4.20 (3.31–5.24) 4.05 (3.18–5.14) 3.83 (3.01–4.75) 3.75 (2.97–4.77)
Palestinian Territory, Occupied 3.31 (2.77–3.93) 3.86 (3.24–4.57) 3.47 (2.72–4.48) 4.04 (3.16–5.13) 3.15 (2.45–3.96) 3.69 (2.87–4.65)
Panama 3.35 (2.84–4.00) 3.39 (2.89–3.98) 3.52 (2.82–4.42) 3.54 (2.79–4.55) 3.18 (2.51–3.99) 3.25 (2.54–4.03)
Papua New Guinea 2.45 (2.04–2.91) 2.45 (2.07–2.86) 2.57 (2.01–3.27) 2.58 (2.01–3.22) 2.32 (1.79–2.93) 2.33 (1.83–2.91)
Paraguay 4.01 (3.38–4.76) 4.31 (3.66–5.09) 4.23 (3.32–5.41) 4.52 (3.55–5.69) 3.80 (3.00–4.72) 4.10 (3.21–5.17)
Peru 3.05 (2.57–3.62) 3.07 (2.58–3.60) 3.20 (2.49–4.08) 3.22 (2.53–4.03) 2.91 (2.23–3.70) 2.91 (2.31–3.69)
Philippines 4.22 (3.55–4.99) 4.29 (3.65–5.10) 4.39 (3.44–5.50) 4.49 (3.50–5.68) 4.05 (3.19–5.09) 4.10 (3.20–5.29)
Poland 3.82 (3.57–4.07) 3.84 (3.61–4.06) 4.02 (3.67–4.40) 4.03 (3.68–4.38) 3.63 (3.29–3.98) 3.66 (3.37–4.00)
Portugal 3.88 (3.64–4.13) 4.24 (3.98–4.51) 4.20 (3.83–4.60) 4.46 (4.07–4.89) 3.58 (3.26–3.93) 4.03 (3.68–4.41)
Qatar 3.53 (2.87–4.28) 4.21 (3.34–5.17) 3.61 (2.78–4.55) 4.29 (3.25–5.44) 3.30 (2.59–4.27) 3.90 (2.98–5.04)
Romania 3.77 (3.21–4.43) 4.12 (3.46–4.83) 3.97 (3.11–4.99) 4.32 (3.42–5.43) 3.58 (2.85–4.41) 3.92 (3.08–4.93)
Russian Federation 3.72 (3.53–3.93) 4.17 (3.95–4.40) 3.91 (3.64–4.24) 4.38 (4.07–4.72) 3.56 (3.29–3.84) 3.99 (3.69–4.29)
Rwanda 1.52 (1.23–1.88) 1.60 (1.31–1.95) 1.59 (1.18–2.11) 1.67 (1.25–2.14) 1.45 (1.07–1.91) 1.53 (1.12–2.03)
Saint Lucia 2.84 (2.54–3.15) 2.93 (2.58–3.30) 2.98 (2.56–3.43) 3.08 (2.60–3.60) 2.72 (2.32–3.16) 2.80 (2.34–3.31)
Saint Vincent and the Grenadines 2.70 (2.29–3.18) 2.82 (2.39–3.32) 2.83 (2.26–3.50) 2.94 (2.30–3.69) 2.58 (2.03–3.24) 2.70 (2.09–3.46)
Samoa 2.15 (1.97–2.36) 2.07 (1.82–2.34) 2.25 (1.99–2.56) 2.16 (1.82–2.57) 2.05 (1.80–2.31) 1.97 (1.66–2.32)
Sao Tome and Principe 2.37 (1.98–2.84) 2.36 (1.97–2.77) 2.48 (1.93–3.19) 2.47 (1.93–3.14) 2.26 (1.74–2.93) 2.25 (1.77–2.87)
Saudi Arabia 2.98 (2.47–3.54) 3.20 (2.63–3.78) 3.08 (2.41–3.92) 3.33 (2.54–4.15) 2.82 (2.17–3.65) 3.03 (2.36–3.90)
Senegal 2.98 (2.49–3.52) 3.15 (2.67–3.71) 3.11 (2.41–3.91) 3.32 (2.55–4.17) 2.85 (2.23–3.59) 2.99 (2.34–3.77)
Serbia 3.21 (2.69–3.79) 3.67 (3.05–4.39) 3.37 (2.67–4.18) 3.87 (2.94–4.95) 3.05 (2.35–3.88) 3.48 (2.68–4.40)
Seychelles 4.36 (3.63–5.20) 4.34 (3.62–5.12) 4.59 (3.54–5.84) 4.57 (3.55–5.74) 4.14 (3.18–5.21) 4.12 (3.21–5.17)
Sierra Leone 2.52 (2.10–2.99) 2.51 (2.11–2.94) 2.64 (2.09–3.34) 2.63 (2.05–3.25) 2.40 (1.88–3.03) 2.39 (1.89–2.96)
Singapore 5.03 (4.28–5.90) 5.14 (4.36–6.02) 5.25 (4.13–6.49) 5.37 (4.22–6.79) 4.81 (3.70–6.07) 4.92 (3.89–6.18)
Slovakia 3.64 (3.07–4.29) 4.23 (3.55–5.00) 3.82 (3.01–4.78) 4.46 (3.51–5.58) 3.48 (2.73–4.36) 4.02 (3.13–4.97)
Slovenia 3.87 (3.52–4.23) 4.23 (3.83–4.67) 4.07 (3.56–4.61) 4.43 (3.86–5.07) 3.68 (3.21–4.22) 4.02 (3.50–4.61)
Solomon Islands 2.26 (1.91–2.65) 2.33 (1.96–2.76) 2.37 (1.85–2.98) 2.44 (1.93–3.11) 2.14 (1.66–2.68) 2.22 (1.74–2.77)
Somalia 2.04 (1.71–2.42) 2.07 (1.77–2.43) 2.14 (1.67–2.69) 2.17 (1.74–2.71) 1.95 (1.53–2.45) 1.97 (1.53–2.51)
South Africa 2.41 (2.28–2.55) 2.48 (2.34–2.62) 2.53 (2.33–2.74) 2.61 (2.41–2.82) 2.30 (2.12–2.50) 2.37 (2.17–2.56)
Spain 3.72 (3.49–3.99) 4.02 (3.77–4.27) 4.01 (3.66–4.41) 4.24 (3.89–4.61) 3.44 (3.15–3.75) 3.81 (3.50–4.15)
Sri Lanka 3.92 (3.33–4.60) 3.87 (3.27–4.54) 4.10 (3.23–5.10) 4.07 (3.16–5.11) 3.75 (2.97–4.66) 3.69 (2.87–4.67)
Sudan 2.31 (1.96–2.71) 2.37 (2.01–2.79) 2.43 (1.92–3.02) 2.49 (1.93–3.17) 2.21 (1.74–2.79) 2.26 (1.77–2.82)
Suriname 2.66 (2.25–3.12) 2.89 (2.43–3.42) 2.79 (2.19–3.48) 3.03 (2.35–3.85) 2.53 (1.99–3.15) 2.76 (2.16–3.51)
Swaziland 2.63 (2.20–3.09) 2.53 (2.16–3.02) 2.77 (2.16–3.48) 2.67 (2.11–3.40) 2.52 (1.99–3.17) 2.42 (1.90–2.99)
Sweden 3.50 (3.32–3.70) 3.65 (3.46–3.85) 3.77 (3.50–4.05) 3.84 (3.56–4.15) 3.23 (3.01–3.47) 3.46 (3.22–3.71)
Switzerland 3.64 (3.41–3.89) 3.61 (3.40–3.85) 3.93 (3.60–4.29) 3.80 (3.48–4.13) 3.36 (3.08–3.67) 3.42 (3.13–3.74)
Syrian Arab Republic 3.80 (3.22–4.46) 4.18 (3.53–4.92) 3.97 (3.13–4.98) 4.37 (3.43–5.49) 3.64 (2.86–4.53) 3.99 (3.10–4.98)
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Table 2 Continued
Total Males Females
1990 2010 1990 2010 1990 2010
Taiwan, Province of China 3.40 (3.12–3.69) 3.92 (3.66–4.17) 3.55 (3.14–3.99) 4.10 (3.72–4.48) 3.23 (2.85–3.61) 3.74 (3.40–4.11)
Tajikistan 5.03 (4.23–5.97) 5.40 (4.64–6.27) 5.29 (4.12–6.55) 5.70 (4.47–7.26) 4.79 (3.76–5.97) 5.13 (4.01–6.36)
Tanzania, United Republic of 2.81 (2.53–3.14) 2.75 (2.45–3.08) 2.94 (2.52–3.43) 2.88 (2.46–3.42) 2.69 (2.28–3.16) 2.62 (2.20–3.08)
Thailand 5.23 (4.82–5.66) 5.31 (4.88–5.75) 5.49 (4.94–6.15) 5.58 (4.97–6.18) 4.99 (4.46–5.58) 5.06 (4.54–5.65)
Timor-Leste 4.59 (3.83–5.38) 4.47 (3.71–5.32) 4.80 (3.78–5.98) 4.69 (3.61–5.91) 4.38 (3.45–5.56) 4.25 (3.39–5.37)
Togo 2.81 (2.40–3.33) 2.78 (2.36–3.34) 2.96 (2.29–3.82) 2.94 (2.30–3.77) 2.67 (2.12–3.35) 2.64 (2.09–3.29)
Tonga 2.61 (2.17–3.10) 2.73 (2.28–3.18) 2.72 (2.10–3.47) 2.88 (2.21–3.61) 2.50 (1.94–3.18) 2.58 (2.00–3.32)
Trinidad and Tobago 2.75 (2.51–3.01) 2.93 (2.63–3.23) 2.90 (2.55–3.28) 3.07 (2.64–3.56) 2.62 (2.30–2.95) 2.80 (2.43–3.19)
Tunisia 4.12 (3.51–4.91) 4.43 (3.72–5.23) 4.31 (3.37–5.44) 4.63 (3.61–5.83) 3.93 (3.09–4.91) 4.24 (3.32–5.34)
Turkey 3.76 (3.50–4.06) 4.10 (3.80–4.43) 3.94 (3.51–4.39) 4.30 (3.85–4.78) 3.59 (3.22–3.97) 3.91 (3.50–4.37)
Turkmenistan 5.10 (4.35–6.06) 5.43 (4.64–6.35) 5.35 (4.27–6.69) 5.69 (4.48–7.14) 4.87 (3.92–6.12) 5.20 (4.12–6.38)
Uganda 1.95 (1.58–2.37) 2.11 (1.75–2.52) 2.05 (1.55–2.68) 2.21 (1.72–2.82) 1.86 (1.39–2.43) 2.00 (1.54–2.54)
Ukraine 3.85 (3.25–4.53) 4.19 (3.56–4.93) 4.05 (3.18–5.00) 4.41 (3.45–5.46) 3.68 (2.88–4.69) 4.01 (3.13–5.05)
United Arab Emirates 3.40 (2.73–4.16) 3.67 (2.97–4.47) 3.50 (2.64–4.48) 3.76 (2.92–4.78) 3.16 (2.38–4.12) 3.43 (2.65–4.39)
UK 3.48 (3.32–3.64) 3.61 (3.45–3.78) 3.75 (3.53–4.02) 3.80 (3.57–4.05) 3.21 (3.02–3.42) 3.42 (3.22–3.63)
USA 3.44 (3.35–3.53) 3.60 (3.50–3.70) 3.62 (3.48–3.77) 3.78 (3.63–3.93) 3.26 (3.14–3.40) 3.43 (3.29–3.56)
Uruguay 2.77 (2.34–3.27) 2.73 (2.32–3.18) 2.90 (2.24–3.65) 2.87 (2.27–3.58) 2.65 (2.09–3.35) 2.60 (2.05–3.28)
Uzbekistan 5.34 (4.50–6.25) 5.63 (4.83–6.53) 5.62 (4.47–6.93) 5.91 (4.67–7.41) 5.08 (4.04–6.39) 5.36 (4.28–6.66)
Vanuatu 2.17 (1.83–2.56) 2.24 (1.90–2.65) 2.26 (1.75–2.88) 2.33 (1.80–2.95) 2.07 (1.63–2.61) 2.14 (1.64–2.70)
Venezuela, Bolivarian Republic of 3.37 (2.84–3.92) 3.55 (3.01–4.18) 3.52 (2.81–4.39) 3.72 (2.92–4.66) 3.22 (2.52–3.98) 3.39 (2.65–4.21)
Viet Nam 4.48 (3.82–5.27) 4.59 (3.81–5.46) 4.67 (3.70–5.88) 4.83 (3.69–6.16) 4.31 (3.35–5.39) 4.37 (3.43–5.47)
Yemen 3.27 (2.76–3.86) 3.37 (2.82–4.05) 3.43 (2.65–4.38) 3.55 (2.74–4.53) 3.13 (2.46–3.94) 3.21 (2.48–4.13)
Zambia 2.27 (1.91–2.69) 2.27 (1.91–2.70) 2.39 (1.84–3.03) 2.38 (1.91–3.00) 2.15 (1.67–2.70) 2.17 (1.70–2.71)
Zimbabwe 3.06 (2.82–3.29) 3.10 (2.81–3.39) 3.21 (2.85–3.59) 3.25 (2.83–3.66) 2.92 (2.59–3.23) 2.95 (2.58–3.39)
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(especially component 1) are larger than the coefﬁ-
cients for income (which were expected to be low). The
assumption of our Bayesian approach is that the ﬁnal
estimations, informed by the raw data, covariates and
regional hierarchy, are closer to the ‘truth’ than any iso-
lated datapoint. A substantial reduction of uncertainty in
the estimates for data-deﬁcient regions and countries
must await the carrying out of good-quality national sur-
veillance studies so that the dependence of ﬁnal esti-
mates on priors, and their associated uncertainties, is
reduced.
We had more limited data across time to quantify tem-
poral trends in intakes. In addition, our analysis evalu-
ated intakes in 1990 and 2010, which does not exclude
larger changes over a broader time horizon. For
instance, reported intakes in Japan,32 Portugal33 and
Finland34 from several decades ago were much higher
than our recent estimates. This implies potentially large
reductions in sodium intakes in these countries over
time frames longer than that covered in our study, con-
sistent with changes in traditional methods of food pres-
ervation made possible by widespread refrigeration.35
Conversely, recent increased global consumption of
highly processed foods36 may be countering or even
reversing these historical associations between modern-
isation and declining sodium intakes.
In May 2013, the 66th World Health Assembly followed
up the 2011 United Nations High-Level Summit on the
Prevention and Control of Non-Communicable Diseases
with a resolution endorsing a global action plan that
included a proposed 30% reduction in salt/sodium
intake.37 Our ﬁndings can help inform the planning and
design of such high-priority programmes. Optimal strat-
egies for reducing sodium will partly depend on the pro-
portion of dietary sodium derived from cooking or table
salt (eg, relatively high in Asian nations) versus prepared or
industrialised foods (eg, the majority in high-income
Western nations).12 In a limited number of high-income
countries, sustained, coordinated public health pro-
grammes have helped lower sodium intakes, for example,
in Japan,38 Finland34 and the UK.39 The most recent sur-
veillance data from the UK (too late for inclusion in our
model) documents a 15% reduction in mean sodium
intakes over the preceding decade, coinciding with a coor-
dinated national programme which includes formal food
industry commitments.40 Media and educational pro-
grammes can also have an impact in countries where sub-
stantial proportions of dietary sodium are added during
household food preparation and at the table.41 Simulations
suggest that population-wide sodium reduction strategies
would not only be cost-effective, but could also be cost-
saving.42–44 While the food industry often cites taste as a
major barrier to sodium reduction, our ﬁndings provide
empiric evidence on the remarkable adaptability of the
human palate to preference for salt,45 with usual sodium
intakes varying more than 2.5-fold across world regions and
fourfold across nations.
Our results also highlight the data gaps and the need
for improved surveillance of sodium intakes using trans-
parent, validated and comparable methods. If a gold
standard were speciﬁed for the national surveillance of
sodium intakes it would likely entail the combination
of repeated national probability sampling and the use of
24 h urine collections biochemically validated for com-
pleteness.22 40 To our knowledge, only the UK has imple-
mented such a system. Yet, despite the limitations of the
primary data sources available to us, our estimates of
mean intakes, interpreted in conjunction with their
uncertainties, indicate that, for virtually all countries, it
is likely to be some time before mean intakes approach
levels at which the beneﬁts of further reduction may be
uncertain.29 Thus, the remaining uncertainties high-
lighted by our work inform the need for enhanced sur-
veillance and further research, but do not alter the
imperative for strong, active public health policies to
reduce national sodium intakes from their current
levels.
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